Speakers:
- WHO CC Representative – TBC
- Ron A.M. Fouchier, Erasmus MC, Rotterdam, The Netherlands will speak on ‘Antigenic variation in H3N2 viruses’
- Esther Kissling, EpiConcept, Paris, France will speak on ‘Available interim vaccine effectiveness (VE) estimates across the northern hemisphere’
- Katja Hoschler, UKHSA, London, UK will speak on ‘Population-based serology: potential susceptibility to K variant’
Webinar co-chairs
Maria Zambon, UKHSA, London, UK and Frederick Hayden, University of Virginia School of Medicine, VA, USA
Register
